BCC.Global Media
In November 2025, Google officially released Gemini 3. The new model simultaneously landed on enterprise-grade platforms such as Vertex AI and Gemini Enterprise, and on day one was integrated into Google Search and Android—compared with previous models like GPT-5 and…
In 2025, the “mass-production storm” of the humanoid-robot industry officially arrived. This year, Tesla’s Optimus began trial production in Fremont; XPeng’s IRON started tightening screws on the Guangzhou factory line; Kepler’s K2 “Bumblebee” was the first to achieve commercial sales;…
Recently, dynamics have been frequent in the AR smart-glasses field. On October 16, INMO Technology took the lead in launching the new-generation AI smart glasses INMO GO3 and announced it would jointly build a native “AI+AR” content ecosystem with companies…
In recent days, domestic humanoid robot companies have continuously released new products and announced new orders, and the heightened industry sentiment driven by short-term event catalysts is encouraging. With ongoing delivery and application in the industrial field, China’s humanoid robot…
“Cutting the card,” “card tray,” and “dual SIM standby”—these keywords that have accompanied Chinese consumers for fifteen years are quietly exiting the stage of history. On October 13, China Unicom, China Mobile, and China Telecom successively announced that they had…
On October 7, 2025, OpenAI delivered a major set of product and strategic updates at its annual developer conference (DevDay 2025)—from built‑in ChatGPT apps to Agent‑based automated shopping, and to the enterprise coding engine Codex being formally commercialized. This sequence…
The year 2025 has become a breakout year for AI drug discovery in China. Companies such as YuanSi Biopeptides, HuaShen AI Pharma, and XtalPi have completed business development (BD) deals worth several billion USD in total. While startups are achieving…
In the summer of 2025, the streets of Chinese cities are swarmed with delivery riders clad in yellow, blue, and red. From food and daily necessities to pharmaceuticals, electronics, and even fashion and cosmetics, the buzz surrounding instant retail is…
On August 28, China’s National Medical Products Administration (NMPA) approved the Investigational New Drug (IND) application for Genekey Biotech’s GKL-006Allo injection, intended for patients with locally advanced or metastatic solid tumors that have failed standard treatments. This marks the official…
In recent years, the home-use medical device market has entered a period of rapid development. According to data from Eshare (医械汇), the market size of home-use medical devices in 2024 reached RMB 262.4 billion (approximately USD 36.1 billion), marking a…